Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
15.30
-0.50 (-3.16%)
At close: Jun 15, 2026
DSE:IBP Market Cap
DSE:IBP has a market cap or net worth of 1.8 billion as of June 16, 2026. Its market cap has increased by 50.49% in one year.
Market Cap
1.80B
Enterprise Value
1.82B
Revenue
221.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.30
Market Cap Chart
Since October 18, 2018, DSE:IBP's market cap has decreased from 4.00B to 1.80B, a decrease of -54.97%. That is a compound annual growth rate of -9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.78B | 34.21% |
| Dec 30, 2025 | 1.32B | 22.58% |
| Dec 30, 2024 | 1.08B | -50.79% |
| Dec 28, 2023 | 2.20B | 14.55% |
| Dec 29, 2022 | 1.92B | -1.34% |
| Dec 30, 2021 | 1.94B | -7.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 9.80B |
| Navana Pharmaceuticals | 7.76B |
| Orion Pharma | 6.65B |
| Techno Drugs | 5.85B |
| Silco Pharmaceuticals | 2.17B |
| Ambee Pharmaceuticals | 1.86B |
| Silva Pharmaceuticals | 1.86B |
| Pharma Aids | 1.80B |